| |
|
|
|
Aptevo Therapeutics Inc.  
|
|
0.7289 -0.012 (-0.02%) |
05-23 16:00 |
|
Open: |
0.741 |
Pre close: |
0.741 |
Target:
|
0.91
|
|
High: |
0.76 |
Low: |
0.71 |
Resistance:
|
0.78
0.84
|
|
Volume: |
290,098 |
Market Cap: |
33M |
Support:
|
0.67
0.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.76
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.77 |
Signal(12,26,9): |
-0.03  |
|
MA(100): |
1.16 |
Stochastic Oscillator |
%K(14,3):
|
41.76 |
|
MA(250): |
3.01 |
%D(3): |
50.65 |
|
Average Volume(K) |
3-Month: |
81254
|
52-Week |
High:
|
5.97 |
|
10-Days: |
34484 |
Low: |
0.67 |
|
RSI |
RSI(14):
|
36.56 |
Change(%): |
-86.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.770 |
Return on Equity (ttm) |
-96.5 |
Shares Out. (M) |
45.09 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
-57.3 |
Shares Float (M) |
43.38 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
72.5 |
% Held by Institutions |
21.20 |
|
Forward EPS |
-1.321 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.910 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.41 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.80 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-48.29 |
P/S |
28714650.00 |
|
Operating Margin |
-190.65 |
Levered Free Cash Flow
(M) |
-25.91 |
P/CF |
-0.68 |
|
|
|
|
|
|
